GO
Loading...

Bristol-Myers Squibb Co

More

  • Final Glance: Pharmaceuticals companies Friday, 17 Apr 2015 | 6:03 PM ET

    Baxter International Inc. fell$. 24 or. 3 percent, to $69.91. Hospira fell$. 21 or. 2 percent, to $87.46. Johnson& Johnson fell$. 21 or. 2 percent, to $99.58.

  • April 17- A large study of Bristol-Myers Squibb Co's Opdivo treatment has been halted after proving the drug is effective against the most common form of lung cancer, the company said, positioning the medicine for far wider use than its already approved lung cancer and melanoma indications. AstraZeneca Plc, Pfizer Inc and other drugmakers are developing their...

  • NYSE stocks posting largest percentage increases Friday, 17 Apr 2015 | 1:17 PM ET

    NEW YORK— A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:. Celanese Corp. rose 15.5 percent to $67.18. Summit Materials rose 6.8 percent to $23.59.

  • Midday Glance: Pharmaceuticals companies Friday, 17 Apr 2015 | 1:17 PM ET

    Baxter International Inc. fell$. 23 or. 3 percent, to $69.92. Bristol-Myers Squibb Co. rose $1.84 or 2.9 percent, to $65.52. Eli Lilly& Co. fell$. 97 or 1.3 percent, to $72.52.

  • A promising treatment from Bristol-Myers Squibb may be fast-tracking toward another approved use after researchers stopped a study early because the drug did better than an older treatment in patients with an advanced form of lung cancer. Shares of the New York drugmaker jumped Friday morning after it said Opdivo fared better than the chemotherapy drug...

  • Early Glance: Pharmaceuticals companies Friday, 17 Apr 2015 | 10:57 AM ET

    Baxter International Inc. fell$. 23 or. 3 percent, to $69.92. Bristol-Myers Squibb Co. rose $1.68 or 2.6 percent, to $65.36. Johnson& Johnson fell$. 23 or. 2 percent, to $99.56.

  • Final Glance: Pharmaceuticals companies Thursday, 16 Apr 2015 | 6:03 PM ET

    Baxter International Inc. fell$. 05 or. 1 percent, to $70.15. Bristol-Myers Squibb Co. rose$. 25 or. 4 percent, to $63.68. Hospira fell$. 02 or percent, to $87.67.

  • Midday Glance: Pharmaceuticals companies Thursday, 16 Apr 2015 | 1:29 PM ET

    Baxter International Inc. fell$. 12 or. 2 percent, to $70.08. Bristol-Myers Squibb Co. rose$. 19 or. 3 percent, to $63.62. Eli Lilly& Co. fell$. 10 or. 1 percent, to $73.61.

  • Final Glance: Pharmaceuticals companies Wednesday, 15 Apr 2015 | 5:57 PM ET

    Baxter International Inc. rose$. 22 or. 3 percent, to $70.20. Bristol-Myers Squibb Co. fell$. 60 or. 9 percent, to $63.43. Eli Lilly& Co. rose$. 25 or. 3 percent, to $73.71.

  • April 15- The Medicines Co's intravenous blood clot preventer can be used in angioplasty procedures, an independent advisory panel to the U.S. Food and Drug Administration said on Wednesday. The recommendation follows a review published by FDA staff on Monday, which supported the approval of the drug. Cangrelor, which won European approval in March, was...

  • Midday Glance: Pharmaceuticals companies Wednesday, 15 Apr 2015 | 2:34 PM ET

    Baxter International Inc. rose$. 48 or. 7 percent, to $70.46. Bristol-Myers Squibb Co. fell$. 27 or. 4 percent, to $63.76. Eli Lilly& Co. rose$. 19 or. 3 percent, to $73.65.

  • LONDON, April 15- Having seen off a hostile $118 billion bid launched a year ago by U.S. rival Pfizer, Anglo-Swedish company AstraZeneca is on the move-- quite literally. Chief Executive Pascal Soriot is making AstraZeneca more nimble as hopes build for its cancer pipeline, but he still has his work cut out to keep 2015 earnings above the floor needed to protect his...

  • Final Glance: Pharmaceuticals companies Tuesday, 14 Apr 2015 | 5:58 PM ET

    Baxter International Inc. rose$. 11 or. 2 percent, to $69.98. Bristol-Myers Squibb Co. rose$. 08 or. 1 percent, to $64.03. Eli Lilly& Co. fell$. 06 or. 1 percent, to $73.46.

  • Midday Glance: Pharmaceuticals companies Tuesday, 14 Apr 2015 | 1:34 PM ET

    Baxter International Inc. rose$. 02 or percent, to $69.89. Bristol-Myers Squibb Co. rose$. 28 or. 4 percent, to $64.23. Hospira rose$. 04 or percent, to $87.68.

  • Early Glance: Pharmaceuticals companies Tuesday, 14 Apr 2015 | 10:42 AM ET

    Baxter International Inc. fell$. 13 or. 2 percent, to $69.74. Bristol-Myers Squibb Co. fell$. 24 or. 4 percent, to $63.71. Eli Lilly& Co. fell$. 27 or. 4 percent, to $73.25.

  • Final Glance: Pharmaceuticals companies Monday, 13 Apr 2015 | 6:00 PM ET

    Baxter International Inc. fell$. 70 or 1.0 percent, to $69.87. Bristol-Myers Squibb Co. fell$. 69 or 1.1 percent, to $63.95. Eli Lilly& Co. fell$. 40 or. 5 percent, to $73.52.

  • Midday Glance: Pharmaceuticals companies Monday, 13 Apr 2015 | 1:19 PM ET

    Baxter International Inc. fell$. 58 or. 8 percent, to $70.00. Bristol-Myers Squibb Co. fell$. 26 or. 4 percent, to $64.38. Pfizer fell$. 26 or. 7 percent, to $35.18.

  • Early Glance: Pharmaceuticals companies Monday, 13 Apr 2015 | 10:27 AM ET

    Baxter International Inc. fell$. 13 or. 2 percent, to $70.44. Bristol-Myers Squibb Co. fell$. 03 or percent, to $64.61. Eli Lilly& Co. fell$. 77 or 1.0 percent, to $73.15.

  • April 13- An intravenous blood clot preventer developed by The Medicines Co should be approved by the U.S. Food and Drug Administration, FDA staff reviewers concluded. The FDA rejected the blood thinner in April last year, after its reviewers took issue with the way a pivotal trial, called Champion- Phoenix, was conducted, and asked the company to reanalyze its...

  • Specialty, generic drug costs drive Medicaid costs up Saturday, 11 Apr 2015 | 12:32 PM ET

    JEFFERSON CITY, Mo.— The high cost of a drug used to treat Medicaid patients with hepatitis C drew scrutiny from lawmakers earlier this year, but other drugs are also driving up the state's costs and likely will continue to do so for several years, government data reveals. From fiscal year 2010 through 2014, drug costs for Missouri's Medicaid program rose 33...